You are here

NHS

Vertex clinches Trikafta and other cystic fibrosis drug reimbursement deal in England

Fierce Pharma

Fri, 06/21/24 - 11:42 am

Vertex Pharmaceuticals

cystic fibrosis

After protests, pharma industry reaches 'landmark' drug spending deal with UK government

Fierce Pharma

Mon, 11/20/23 - 11:28 am

NICE changes its mind on Lilly's Mounjaro for diabetes

Pharmaphorum

Fri, 09/8/23 - 10:09 am

BMS’ Sotyktu cleared for NHS use in psoriasis

Pharmaphorum

Thu, 06/29/23 - 11:33 am

Bristol Myers Squibb

AbbVie and Lilly have sent a warning signal to the UK government by leaving the voluntary medicines pricing agreement in protest over increasingly punitive revenue clawbacks

ABPI

Tue, 01/17/23 - 10:38 am

Amgen's high-profile cancer med Lumakras set for rollout in England thanks to NHS access deal

Fierce Pharma

Sat, 09/11/21 - 10:18 pm

Nvidia to build the UK’s fastest supercomputer for AI drug-hunters at GSK, AstraZeneca and more

Fierce Biotech

Mon, 10/5/20 - 11:48 am

artificial intelligence

Life-Saving HIV Drug PrEP On NHS Delayed Amid Coronavirus Pandemic

Forbes

Fri, 06/5/20 - 10:38 am

Sanofi’s Dupixent funded in Wales and Scotland for adolescents with eczema

Pharmaforum

Mon, 01/27/20 - 10:38 am

atopic dermatitis

GW confident epilepsy drug will get NHS funding despite NICE rejection

Pharmaforum

Fri, 08/23/19 - 12:08 pm

NICE recommends funding for psoriasis and type 1 diabetes drugs

Pharmaforum

Fri, 07/12/19 - 12:14 pm

After years of delays, NICE backs Celgene’s Revlimid in first-line MM

Pharmaforum

Fri, 05/17/19 - 07:18 pm

Multiple Myeloma

Vertex CEO, CCO head for U.K. hearing on Orkambi pricing standoff

Fierce Pharma

Mon, 03/4/19 - 07:49 pm

Vertex Pharmaceuticals

cystic fibrosis

Novartis’ CAR-T cancer drug available on NHS to young people

Pharmaforum

Sat, 11/17/18 - 12:34 pm

refractory B-cell acute lymphoblastic leukemia

While controversy over Brexit reaches full boil, a pharma trade group sees the upside in a draft deal

Endpoints

Fri, 11/16/18 - 12:13 pm

pharma industry

NHS, Gilead reach agreement for Yescarta

BioCentury

Sat, 10/6/18 - 12:50 pm

Gilead Sciences

NICE rejects Novartis’ CAR-T in adult lymphoma

Pharmaforum

Wed, 09/19/18 - 11:22 pm

diffuse large B-cell lymphoma

NHS Ordered To Cover Gilead’s HIV Drug In Court Ruling

Xtalks

Fri, 08/5/16 - 11:11 am

Gilead Sciences

Pfizer's leukemia drug approved by UK cost watchdog after previous rejection

BioPharma Dive

Mon, 07/11/16 - 09:11 am

Pfizer to cover NHS docs' script-switching costs in latest Lyrica-protecting move

Fierce Pharma

Tue, 08/11/15 - 07:03 pm

Pages